Options trader Nishant Pant breaks down a bull call spread on this stock.
Category: Uncategorized
Shares of this under-the-radar weight-loss drug play could double, says Leerink Partners
The investment firm initiated coverage of the biopharma stock at a outperform rating.
What Wall Street is expecting from Apple’s iPhone event
Wall Street is looking to see if Apple’s iPhone launch on Tuesday could spark sales and renew investor enthusiasm on the beaten-down stock.
How to trade an improving outlook for bank stocks going forward
Frank Holland breaks down what traders are watching ahead of the new session.
Here are Tuesday’s biggest analyst calls: Nvidia, Apple, Dell, Nike, Dick’s, Robinhood, Meta, MSG Sports & more
Here are Tuesday’s biggest calls on Wall Street.
Dick’s Sporting Goods will thrive now that Foot Locker deal is complete, Citi says
Dick’s Sporting Goods is a “winner in athletic retail” after completing its acquisition of Foot Locker, according to Citi.
Barclays raises Oracle price target ahead of quarterly results
Analyst Raimo Lenschow thinks this report “will be very different versus other years.”
Investor Peter Andersen is disappointed in Apple’s ‘embarrassing absence’ in AI ahead of iPhone event
Peter Andersen of Andersen Capital Management joined CNBC’s “Power Lunch” on Monday to offer his take on a few key market movers.
Santoli’s market wrap-up: Stocks regain steady, snoozy state with reliance on big caps
Mike wraps up Monday’s action, noting investors’ continued preference for larger big-cap tech stocks.
What Goldman’s deal with T. Rowe Price means for private assets in your 401(k)
Here is how the landscape is shaping up for alternative assets in 401(k)s